INTERLEUKINS

Open Access
Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program
Atul Deodhar, Denis Poddubnyy, Proton Rahman, Jeorg Ermann, Tetsuya Tomita, Rebeca Bolce, Soyi Liu Leage, Andris Kronbergs, Caroline Johnson, Joana Araújo, Ann Leung and Désirée van der Heijde

The Journal of Rheumatology August 1 2023, 50 (8) 1020-1028; DOI: https://doi.org/10.3899/jrheum.221022
You have access
Anti-interleukin 6 Therapy Effect for Refractory Joint and Skin Involvement in Systemic Sclerosis: A Real-world, Single-center Experience
Stylianos T. Panopoulos, Maria G. Tektonidou, Vasiliki-Kalliopi Bournia, Aikaterini Arida and Petros P. Sfikakis

The Journal of Rheumatology January 1 2022, 49 (1) 68-73; DOI: https://doi.org/10.3899/jrheum.210273
Open Access
Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients
Ana-Maria Orbai, Iain B. McInnes, Laura C. Coates, M. Elaine Husni, Dafna D. Gladman, Laure Gossec, Luminita Pricop, Olivier Chambenoit, Xiangyi Meng and Philip J. Mease

The Journal of Rheumatology June 1 2020, 47 (6) 854-864; DOI: https://doi.org/10.3899/jrheum.190507
Open Access
Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial
Kamal N. Bharucha, Hermine I. Brunner, Inmaculada Calvo Penadés, Irina Nikishina, Nadina Rubio-Pérez, Sheila Oliveira, Katarzyna Kobusinska, Heinrike Schmeling, Flavio Sztajnbok, Frank Weller-Heinemann, Elena Zholobova, Francesco Zulian, Roger Allen, Jeffrey Chaitow, James Frane, Chris Wells, Nicolino Ruperto, Fabrizio De Benedetti and for the Paediatric Rheumatology International Trials Organisation and the Pediatric Rheumatology Collaborative Study Group

The Journal of Rheumatology August 1 2018, 45 (8) 1173-1179; DOI: https://doi.org/10.3899/jrheum.170326
You have access
Efficacy and Safety of Subcutaneous and Intravenous Loading Dose Regimens of Secukinumab in Patients with Active Rheumatoid Arthritis: Results from a Randomized Phase II Study
Witold Tlustochowicz, Proton Rahman, Bruno Seriolo, Gerhard Krammer, Brian Porter, Albert Widmer and Hanno B. Richards

The Journal of Rheumatology March 1 2016, 43 (3) 495-503; DOI: https://doi.org/10.3899/jrheum.150117
You have access
Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab
Shumpei Yokota, Yasuhiko Itoh, Tomohiro Morio, Naokata Sumitomo, Kaori Daimaru and Seiji Minota

The Journal of Rheumatology April 1 2015, 42 (4) 712-722; DOI: https://doi.org/10.3899/jrheum.140288
You have access
Rilonacept for Gout Flare Prevention in Patients Receiving Uric Acid-lowering Therapy: Results of RESURGE, a Phase III, International Safety Study
John S. Sundy, H. Ralph Schumacher, Alan Kivitz, Steven P. Weinstein, Richard Wu, Shirletta King-Davis and Robert R. Evans

The Journal of Rheumatology August 1 2014, 41 (8) 1703-1711; DOI: https://doi.org/10.3899/jrheum.131226
You have access
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
Mark C. Genovese, Patrick Durez, Hanno B. Richards, Jerzy Supronik, Eva Dokoupilova, Jacob A. Aelion, Sang-Heon Lee, Christine E. Codding, Herbert Kellner, Takashi Ikawa, Sophie Hugot, Gregory Ligozio and Shephard Mpofu

The Journal of Rheumatology March 1 2014, 41 (3) 414-421; DOI: https://doi.org/10.3899/jrheum.130637
Open Access
Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan
Takao Koike, Masayoshi Harigai, Shigeko Inokuma, Naoki Ishiguro, Junnosuke Ryu, Tsutomu Takeuchi, Syuji Takei, Yoshiya Tanaka, Yoko Sano, Hitomi Yaguramaki and Hisashi Yamanaka

The Journal of Rheumatology January 1 2014, 41 (1) 15-23; DOI: https://doi.org/10.3899/jrheum.130466
You have access
Tocilizumab Inhibits Structural Joint Damage and Improves Physical Function in Patients with Rheumatoid Arthritis and Inadequate Responses to Methotrexate: LITHE Study 2-year Results
ROY M. FLEISCHMANN, ANNE-MARIE HALLAND, MAREK BRZOSKO, RUBEN BURGOS-VARGAS, CHRISTOPHER MELA, EMMA VERNON and JOEL M. KREMER

The Journal of Rheumatology February 1 2013, 40 (2) 113-126; DOI: https://doi.org/10.3899/jrheum.120447

Main menu

User menu

Search

INTERLEUKINS

Content

Resources

Subscribers

More